Journal of Infection
Volume 61, Issue 2 , Pages 173-184 , August 2010

Amphotericin B regulates the host immune response in visceral leishmaniasis: Reciprocal regulation of protein kinase C isoforms

  • Asok Kumar Mukherjee

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • Employees State Insurance Hospital, Maniktala, Kolkata, India
    • ,
  • Gaurav Gupta

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Surajit Bhattacharjee

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Subhasis Kamal Guha

      Affiliations

    • School of Tropical Medicine, Kolkata, India
    • ,
  • Saikat Majumder

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Anupam Adhikari

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Parna Bhattachrya

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Suchandra Bhattacharyya Majumdar

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • ,
  • Subrata Majumdar

      Affiliations

    • Div. of Molecular Medicine, Bose Institute, Kolkata, India
    • Corresponding Author InformationCorresponding author at: Div. of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India. Tel.: +91 2337 9416/9544/9219; fax: +91 (33) 2334 3886.

,Accepted 13 May 2010.

References 

  1. Cruz I, Nieto J, Moreno J, Cañavate C, Desjeux P, Alvar J. Leishmania/HIV co-infections in the second decade. Indian J Med Res. 2006;123:357–388
  2. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24:684–703
  3. Sundar S, Rai M. Treatment of visceral leishmaniasis. Expert Opin Pharmacother. 2005;6:2821–2829
  4. López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, et al. Spanish HIV-Leishmania Study Group Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother. 2004;53:540–543
  5. O’Neil MG, Lapointe M. Administration of amphotericin B in lipid emulsion. 892-3; author reply Crit Care Med. 1997;25:893–894
  6. Little JR, Plut EJ, Kotler-Brajtburg J, Medoff G, Kobayashi GS. Relationship between the antibiotic and immunoadjuvant effects of amphotericin B methyl ester. Immunochemistry. 1978;15:219–224
  7. Little JR, Wolf JE. Immunologic effects of amphotericin B. Clin Immunol News. 1987;8:183–185
  8. Lohr KM, Snyderman R. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes. J Immunol. 1982;129:1594–1599
  9. Mehta RT, Mehta K, Lopez-Berestein G, Juliano RL. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect Immun. 1985;47:429–433
  10. Sarthou P, Primi D, Cazenave PA. B cell triggering properties of a nontoxic derivative of amphotericin B. J Immunol. 1986;137:2156–2161
  11. Shirley SF, Little JR. Immunopotentiating effects of amphotericin BII. Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol. 1979;123:2883–2889
  12. Van der Auwera P. The immunomodulating effects of antibiotics. Curr Opin Infect Dis. 1988;1:363–374
  13. Arning M, Kliche KO, Heer-Sonderhoff AH, Wehmeier A. Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycoses. 1995;38:459–465
  14. Cleary JD, Weisdorf D, Fletcher CV. Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell Clin Pharm. 1988;22:769–772
  15. Matsuo K, Hotokezaka H, Ohara N, Fujimura Y, Yoshimura A, Okada Y, et al. Analysis of amphotericin B-induced cell signaling with chemical inhibitors of signaling molecules. Microbiol Immunol. 2006;50:337–347
  16. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev. 2001;101:2353–2364
  17. Salonen T, Sareila O, Jalonen U, Kankaanranta H, Tuominen R, Moilanen E. Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages. Br J Pharmacol. 2006;147:790–799
  18. Yadav M, Clark L, Schorey JS. Macrophage’s proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase. J Immunol. 2006;176:5494–5503
  19. Bhattacharyya S, Ghosh S, Sen P, Roy S, Majumdar S. Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani. Mol Cell Biochem. 2001;216:47–57
  20. Murray HW. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother. 2001;45:2185–2197
  21. Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol. 2005;174:7160–7171
  22. Hart DT, Vickerman K, Coombs GH. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology. 1981;82:345–355
  23. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45–50
  24. Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, Majumdar S. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis. 2002;185:1704–1708
  25. Ghose AC, Mookerjee A, Sengupta K, Ghosh AK, Dasgupta S, Ray PK. Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals. Immunol Lett. 1999;65:175–181
  26. Moulakakis C, Adam S, Seitzer U, Schromm AB, Leitges M, Stamme C. Surfactant protein A activation of atypical protein kinase C zeta in IkappaB- alpha-dependent anti-inflammatory immune regulation. J Immunol. 2007;179:4480–4491
  27. Majumdar S, Kane LH, Rossi MW, Volpp BD, Nauseef WM, Korchak HM. Protein kinase C isotypes and signal transduction in human neutrophils: selective substrate specificity of calcium dependent b-PKC and novel calcium independent n-PKC. Biochim Biophys Acta. 1993;1176:276–286
  28. Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, et al. Leishmania donovani suppresses activator protein-1 and NF-kB in host macrophages via ceramide generation: involvement of extracellular signal regulated kinase. Infect Immun. 2002;70:6828–6838
  29. Schreck R, Baeuerle PA. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Meth Enzymol. 1994;234:151–163
  30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–138
  31. Chia JK, Pollack M. Amphotericin B induces tumor necrosis factor production by murine macrophages. J Infect Dis. 1989;159:113–116
  32. Amer AO, Swanson MS. Phagosome of one’s own: a microbial guide to life in the macrophage. Curr Opin Microbiol. 2002;5:56–61
  33. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol. 2001;167:893–901
  34. Rogers KA, Dekrey GK, Mbow ML, Gillespie RD, Brodskyn CT, Titus RG. Type 1 and type 2 responses to Leishmania major. FEMS Microbiol Lett. 2002;209:1–7
  35. Diefenbach A, Schindler H, Röllinghoff M, Yokoyama WM, Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science. 1999;284:951–955
  36. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, et al. TGF-β in leishmanial infection: a parasite escape mechanism. Science. 1992;257:545–548
  37. Gradoni L, Bryceson A, Desjeux P. Treatment of Mediterranean visceral leishmaniasis. Bull World Health Organ. 1995;73:191–197
  38. Jha TK, Giri YN, Singh TK, Jha S. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India. Am J Trop Med Hyg. 1995;52:536–538
  39. Davidson RN, Russo R. Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin Infect Dis. 1994;19:560
  40. Saha AK, Mukherjee T, Bhaduri A. Mechanism of action of amphotericin B on Leishmania donovani promastigotes. Mol Biochem Parasitol. 1986;19:195–200
  41. Wolf JE, Massof SE. In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect Immun. 1990;58:1296–1300
  42. Reyes E, Cardona J, Prieto A, Bernstein ED, Rodríguez-Zapata M, Pontes MJ, et al. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells. J Infect Dis. 2000;181:2003–2010
  43. Berman JD, Wyler DJ. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis. 1980;142:83–86
  44. Patel R. Antifungal agents. Part I. Amphotericin B preparations and flucytosine. Mayo Clin Proc. 1998;73:1205–1225
  45. Stenger S, Thuring H, Rollinghoff M, Bogdan NC. Tissue expression in inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med. 1994;180:783–789
  46. Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S, et al. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J Immunol. 1990;144:4794–4797
  47. De-Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis. 1995;21:162–165
  48. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med. 1996;183:1501–1514
  49. Murray HW, Nathan CF. Macrophage microbicidal mechanisms in vivo: reactive nitrogen vs oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med. 1999;189:741–746
  50. Bhattacharyya S, Ghosh S, Jhonson PL, Bhattacharya SK, Majumdar S. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect Immun. 2001;69:1499–1507
  51. Wadhone P, Maiti M, Agarwal R, Kamat V, Martin S, Saha B. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response. J Immunol. 2009;182:7146–7154
  52. Mookerjee Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, et al. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother. 2006;50:1788–1797
  53. Dey R, Majumder N, Bhattacharjee S, Majumdar SB, Banerjee R, Ganguly S, et al. Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase. Infect Immun. 2007;75:2136–2142
  54. Dekker LV, Leitges M, Altschuler G, Mistry N, McDermott A, Roes J, et al. Protein kinase C-β contributes to NADPH oxidase activation in neutrophils. Biochem J. 2000;347:285–289
  55. Dey R, Sarkar A, Majumder N, Bhattacharyya Majumdar S, Roychoudhury K, Bhattacharyya S, et al. Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis. Infect Immun. 2005;73:8334–8344
  56. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol. 2007;179:5592–5603

PII: S0163-4453(10)00149-0

doi: 10.1016/j.jinf.2010.05.003

Journal of Infection
Volume 61, Issue 2 , Pages 173-184 , August 2010

Article Tools

* Image Usage & Resolution